During the last three months, 6 analysts shared their evaluations of Agilent Technologies A, revealing diverse outlooks from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 2 | 3 | 1 | 0 |
Last 30D | 0 | 0 | 1 | 0 | 0 |
1M Ago | 0 | 0 | 0 | 0 | 0 |
2M Ago | 0 | 0 | 1 | 0 | 0 |
3M Ago | 0 | 2 | 1 | 1 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $146.67, a high estimate of $160.00, and a low estimate of $135.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 1.68%.
Diving into Analyst Ratings: An In-Depth Exploration
A clear picture of Agilent Technologies's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Luke Sergott | Barclays | Raises | Equal-Weight | $145.00 | $135.00 |
Derik De Bruin | B of A Securities | Lowers | Neutral | $150.00 | $153.00 |
Brandon Couillard | Wells Fargo | Lowers | Overweight | $155.00 | $157.00 |
Luke Sergott | Barclays | Lowers | Underweight | $135.00 | $145.00 |
Eve Burstein | Bernstein | Lowers | Market Perform | $135.00 | $140.00 |
Rachel Vatnsdal | JP Morgan | Lowers | Overweight | $160.00 | $165.00 |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Agilent Technologies. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Agilent Technologies compared to the broader market.
- Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Agilent Technologies's stock. This comparison reveals trends in analysts' expectations over time.
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Agilent Technologies's market position. Stay informed and make well-informed decisions with our Ratings Table.
Stay up to date on Agilent Technologies analyst ratings.
Unveiling the Story Behind Agilent Technologies
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Financial Milestones: Agilent Technologies's Journey
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: Agilent Technologies displayed positive results in 3 months. As of 31 October, 2024, the company achieved a solid revenue growth rate of approximately 0.77%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.
Net Margin: Agilent Technologies's net margin is impressive, surpassing industry averages. With a net margin of 20.63%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Agilent Technologies's ROE stands out, surpassing industry averages. With an impressive ROE of 5.95%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Agilent Technologies's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 3.07%, the company showcases efficient use of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.57.
Understanding the Relevance of Analyst Ratings
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.